附录B：美国神经病学学会临床医生循证指南摘要：肉毒杆菌神经毒素在运动障碍治疗中的应用 - Suppr | 超能文献

APPENDIX B: AAN Summary of Evidence-Based Guidelines for Clinicians: Use of Botulinum Neurotoxin for the Treatment of Movement Disorders.

出版信息

Continuum (Minneap Minn). 2010 Feb;16(1 Movement Disorders):180-2. doi: 10.1212/01.CON.0000368200.74266.0f.

DOI:10.1212/01.CON.0000368200.74266.0f

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

APPENDIX B: AAN Summary of Evidence-Based Guidelines for Clinicians: Use of Botulinum Neurotoxin for the Treatment of Movement Disorders.附录B：美国神经病学学会临床医生循证指南摘要：肉毒杆菌神经毒素在运动障碍治疗中的应用

Continuum (Minneap Minn). 2010 Feb;16(1 Movement Disorders):180-2. doi: 10.1212/01.CON.0000368200.74266.0f.

2

APPENDIX B: AAN Summary of Evidence-Based Guidelines for Clinicians: Management Issues for Women With Epilepsy-Focus on Pregnancy: Obstetrical Complications and Change in Seizure Frequency.附录B：美国神经病学学会临床医生循证指南总结：癫痫女性的管理问题——聚焦妊娠：产科并发症与癫痫发作频率变化

Continuum (Minneap Minn). 2010 Jun;16(3 Epilepsy):257-9. doi: 10.1212/01.CON.0000368246.25846.40.

3

APPENDIX C: AAN Summary of Evidence-Based Guidelines for Clinicians: Management Issues for Women With Epilepsy-Teratogenesis and Perinatal Outcomes.附录C：美国神经病学学会临床医生循证指南总结：癫痫女性的管理问题——致畸作用与围产期结局

Continuum (Minneap Minn). 2010 Jun;16(3 Epilepsy):260-2. doi: 10.1212/01.CON.0000368247.02976.ad.

4

APPENDIX D: AAN Summary of Evidence-Based Guidelines for Clinicians: Management Issues for Women With Epilepsy-Vitamin K, Folic Acid, Blood Levels, and Breast-feeding.附录D：美国神经病学学会临床医生循证指南摘要：癫痫女性的管理问题——维生素K、叶酸、血药浓度及母乳喂养

Continuum (Minneap Minn). 2010 Jun;16(3 Epilepsy):263-6. doi: 10.1212/01.CON.0000368248.02976.49.

5

APPENDIX A: AAN Summary of Evidence-Based Guideline for Clinicians: Evaluating an Apparent Unprovoked First Seizure in Adults.附录A：美国神经病学学会（AAN）临床医生循证指南摘要：评估成人首次明显无诱因癫痫发作

Continuum (Minneap Minn). 2010 Jun;16(3 Epilepsy):255-6. doi: 10.1212/01.CON.0000368245.18223.59.

6

Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review) [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.评估：肉毒杆菌神经毒素治疗自主神经功能障碍和疼痛（循证综述）[已停用]：美国神经病学学会治疗与技术评估小组委员会报告

Neurology. 2008 May 6;70(19):1707-14. doi: 10.1212/01.wnl.0000311390.87642.d8.

7

Treatment with botulinum neurotoxin of gastrointestinal smooth muscles and sphincters spasms.肉毒杆菌神经毒素治疗胃肠道平滑肌和括约肌痉挛。

Mov Disord. 2004 Mar;19 Suppl 8:S146-56. doi: 10.1002/mds.20070.

8

The application of botulinum toxin in the prostate.肉毒杆菌毒素在前列腺中的应用。

J Urol. 2006 Dec;176(6 Pt 1):2375-82. doi: 10.1016/j.juro.2006.07.127.

9

A capillary electrophoresis method to assay catalytic activity of botulinum neurotoxin serotypes: implications for substrate specificity.一种用于检测肉毒杆菌神经毒素血清型催化活性的毛细管电泳方法：对底物特异性的影响

Anal Biochem. 2007 Jul 15;366(2):207-17. doi: 10.1016/j.ab.2007.04.048. Epub 2007 May 3.

10

Human T-cell responses to botulinum neurotoxin: proliferative responses in vitro of lymphocytes from botulinum neurotoxin A-treated movement disorder patients.人类 T 细胞对肉毒神经毒素的反应：肉毒神经毒素 A 治疗运动障碍患者的淋巴细胞体外增殖反应。

J Neuroimmunol. 2011 Aug 15;237(1-2):66-72. doi: 10.1016/j.jneuroim.2011.06.005. Epub 2011 Jul 6.